The data included counts of persons and services, average provider fees and Medicare benefits.
4. The average cycle-based provider fees, benefits and out-of-pocket expenses for each of the three cycle types were calculated by summing weighted averages for each of the MBS items associated with a Fresh, Frozen and IUI cycle (Table 1). 5. MBS Items 13200 and 13201 were used to uniquely identify utilisation of Fresh Cycles and MBS Item 13218 was used to uniquely identify Frozen Cycles.
To evaluate the impact of the EMSNCaps on ART and IUI access by female age (<32, 32-33, 36-37, 36-37, 38-39, 40-41, 42 + years) Medicare provided quarterly averages of the provider fees charged, Medicare benefits paid and out-of-pocket expenses for the different cycle types.
Compared to the average official provider-fees for c-sections charged in FBO hospitals (12,000 TSZ/10 USD), this means that rural patients had to spend approximately 40% of their monthly income to receive such services.
The reduction in provider fees associated with MIP in this group represented roughly 1/3 of the average spending on providers and 1/2 of the average spending on drugs for non-MIP insured individuals with acute illnesses.
The reduction in out-of-pocket expenditures for provider fees within this group (approximately 15 Gel) was also not statistically significant and represented only 20% of the average out-of-pocket expenditures on health care providers among non-MIP insured chronic disease patients.
Therefore, provider fees would foreseeably cost another ($122 + $204 /60 min = $5 per minute to the hospital.
Provider fees vary based on means of compensation from fixed salary to hourly wages.
These figures do not account for implant costs and provider fees.
1. Dollar figures for provider fees and Medicare benefits were converted to constant 2010 dollars using the ABS Health Price Index [ 11]. 2. Provider fees and Medicare benefits for each MBS item were calculated as the total average fee and benefits divided by the no of services.
